159556-73-7

Usage

Uses

Used in Pharmaceutical Industry:
Loratadine is used as an antihistamine medication for the treatment of allergic symptoms such as sneezing, runny nose, itching, and watery eyes. It is particularly effective in managing symptoms caused by hay fever or other allergies.
Used in Over-the-Counter Medications:
Loratadine is used as an active ingredient in various over-the-counter forms such as tablets, syrup, and chewable tablets, making it easily accessible for individuals seeking relief from allergy symptoms.
Used for Minimal Side Effects:
Loratadine is used as a non-sedating antihistamine, ensuring minimal side effects such as drowsiness, making it a preferred choice for individuals who require allergy relief without the risk of sedation.
Overall, 2,2-dimethyl-1-(diphenylmethyl)-3-azetidinol, or loratadine, is a widely used and effective medication for managing allergy symptoms, offering convenience and minimal side effects in its various forms.

Upstream product

• 159556-72-6 2,2-dimethyl-1-(diphenylmethyl)-3-azetidone 
• 2648-71-7 3-bromo-3-methyl-2-butanone 
• 159556-71-5 3-<(diphenylmethyl)amino>-3-methyl-2-butanone 
• 1026444-67-6 3-(benzhydrylamino)-1-bromo-3-methylbutan-2-one 
• 91-00-9 Benzhydrylamine 

Downstream Products

• 159556-76-0 2,2-dimethyl-1-(diphenylmethyl)-3-<(tolylsulfonyl)oxy>azetidine 
• 133891-73-3 3-amino-2,2-dimethyl-1-(diphenylmethyl)azetidine 
• 149105-89-5 3-amino-2,2-dimethylazetidine 

Relevant academic research and scientific papers

Pyrimidine amine compound, and preparation method and application thereof

The invention discloses a polycyclic compound, and a preparation method and an application thereof. The invention provides the polycyclic compound represented by formula I, or a pharmaceutically acceptable salt thereof. The compound has a relatively good inhibition effect on CDK7.

SUBSTITUTED PYRAZOLO[1,5-A]PYRIDINE COMPOUNDS AS INHIBITORS OF FGFR TYROSINE KINASES

Provided herein are compounds of the general Formula I: and stereoisomers and pharmaceutically acceptable salts or solvates thereof, in which Ring A, Ring B, Ring C, R1, R2, L, Y, and W have the meanings given in the specification, which are inhibitors of FGFR1, FGFR2, FGFR3 and/or FGFR4 and are useful in the treatment and prevention of diseases which can be treated with an FGFR inhibitor, including diseases or disorders mediated by FGFR1, FGFR2, FGFR3 and/or FGFR4.

7-Azetidinylquinolones as antibacterial agents. 2. Synthesis and biological activity of 7-(2,3-disubstituted-1-azetidinyl)-4-oxoquinoline- and -1,8-naphthyridine-3-carboxylic acids. Properties and structure-activity relationships of quinolones with an aze

A series of 7-(2,3-disubstituted-1-azetidinyl)-1,4-dihydro-6-fluoro-4- oxoquinoline- and -1,8-naphthyridine-3-carboxylic acids, with varied substituents at the 1-, 5-, and 8-positions, was prepared to study the effects on potency and physicochemical prope